Table 2.
Systemic Therapy | Number of Patients with Severe Psoriasis (%) |
---|---|
Methotrexate | 2114 (58.7%) |
Psoralen | 607 (16.9%) |
Azathioprine | 582 (16.2%) |
Cyclosporine | 390 (10.8%) |
Etretinate or acetretin | 333 (9.2%) |
Hydroxyurea | 208 (5.8%) |
Mycophenolate mofetil | 9 (0.3%) |
Percentages do not add up to 100 because patients could have received more than 1 systemic therapy